Keiko Shoji

Medicine · Health Sciences

12h-index906citations57works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(18), PI3K/AKT/mTOR signaling in cancer(15), Cancer Genomics and Diagnostics(6), Ovarian cancer diagnosis and treatment(5), DNA and Nucleic Acid Chemistry(3)

Publications57 total

Supplementary Figure 1 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Tables 1-5 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 1 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 5 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 2 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Tables 1-5 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 3 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Data from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Data from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 4 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Methods from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 6 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 2 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 6 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Methods from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 5 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 3 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 4 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
An Attempt to Grasp Resonance during Co-Creation with Biosignal Indicators
Proceedings of the Design Society·2022· 2 citedOpen Access
heisei 27 nedo kankyo oyobi jizokukanounasyakai no bunya ni okeru keizaikyoryokukaihatsukikou tono renkei ni kansuru tyousa tou gyoumu
2016
page 1 of 3Next →

Frequent Co-authors

Katsutoshi Oda(30), Yuji Taketani(23), Hiroyuki Kuramoto(22), Frank McCormick(20), Luika Timmerman(16), Pablo Rodriguez‐Viciana(16), David Stokoe(16), Zachary A. Knight(16), Kevan M. Shokat(16), Jennifer Okada(15), Shunsuke Nakagawa(12), Hiroyuki Aburatani(11), Yuji Ikeda(11), Kei Kawana(10), Osamu Wada‐Hiraike(9), Tomoko Kashiyama(8), Tetsu Yano(8), Yuriko Uehara(7), Y. Taketani(6), Michihiro Tanikawa(6)